A. Parekh

发表

Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.

M. Mandal, I. Pal, S. Rajput, 2013, Life sciences.

Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model

M. Mandal, A. Parekh, Sukhen C Ghosh, 2015, Cancer biology & therapy.

Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer.

C. K. Das, M. Mandal, A. Parekh, 2019, Biochimica et biophysica acta. Molecular cell research.

Progressing Towards a Human-Centric Approach in Cancer Research

C. K. Das, M. Mandal, A. Parekh, 2022, Frontiers in oncology.

Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy.

M. Mandal, I. Pal, K. Dey, 2017, Biochimica et biophysica acta. General subjects.

Glucose Directly Promotes Antifungal Resistance in the Fungal Pathogen, Candida spp.

M. Mandal, A. Parekh, S. Mandal, 2014, The Journal of Biological Chemistry.

Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion.

I. Banerjee, M. Mandal, R. Sen, 2017, Cellular signalling.

Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells

Soumen Kumar Das, M. Mandal, D. Das, 2018, Scientific Reports.

Wavelet-based multiscale analysis of bioimpedance data measured by electric cell-substrate impedance sensing for classification of cancerous and normal cells.

M. Mandal, D. Das, K. Biswas, 2015, Physical review. E, Statistical, nonlinear, and soft matter physics.

Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling

M. Mandal, A. Mazumdar, S. Rajput, 2013, BMC Cancer.

GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling

M. Mandal, I. Pal, A. Parekh, 2016, Cell Death and Disease.

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo

B. C. Jena, C. K. Das, G. Mills, 2018, Oncogene.

Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.

B. C. Jena, C. K. Das, I. Banerjee, 2018, Molecular pharmaceutics.

Abstract 4022: Integrin β1 regulates doxorubicin resistance in breast cancer via FAK-mediated activation of ERK1 pathway

B. C. Jena, M. Mandal, Pralay Mitra, 2018, Tumor Biology.

Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach

M. Mandal, I. Pal, S. Rajput, 2015, Tumor Biology.

Polyploid giant cancer cells induce growth arrest and cytoskeletal rearrangement in breast cancer cells

B. C. Jena, M. Mandal, A. Parekh, 2018, New Biotechnology.

A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance.

C. K. Das, M. Mandal, I. Banerjee, 2023, Biochimica et biophysica acta. Molecular basis of disease.

Glucose Directly Promotes Antifungal Resistance in the

M. Mandal, A. Parekh, S. Mandal, 2014 .

Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells

Soumen Kumar Das, M. Mandal, D. Das, 2018, Scientific Reports.